• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Cosmetics
  • Draft of Prohibited List and Existing List of Cosmetic Ingredients Announced

Draft of Prohibited List and Existing List of Cosmetic Ingredients Announced

Friday, 26 February 2021 / Published in Cosmetics, News, NMPA Registration in China

Draft of Prohibited List and Existing List of Cosmetic Ingredients Announced

On January 22, 2021, the NIFDC (China National Institutes for Food and Drug Control) released an amendment draft for the prohibited list of cosmetic ingredients in China. The new prohibited list (draft) aims to increase its adaptability to the evolving needs of market surveillance of cosmetics products in China.

The NIFDC proposed several work items to update the prohibited list including, but not limited to the following:

  • Banning 17 new raw materials for use in cosmetics
  • Revising the product information of 13 existing raw materials
  • Revising the naming requirements of 27 prohibited plant (animal) raw materials

On January 26, 2021, the NIFDC released an amendment draft of the IECIC (Inventory of Existing Cosmetic Ingredients in China) list. The initial version was published in 2014, and last updated in 2015, covering a total of 8,783 existing raw materials in the list.

The revision of the IECIC helps to ensure the safety use of cosmetics whilst the updated database of raw materials will be referred for risk assessment on the product safety of cosmetics.

What’s new?

  • The IECIC list (draft) added newly approved raw materials: camel hump oil, samara oil, elaeagnus mollis diel, glabridin, ethyl lauroyl arginate HCL, methoxy PEG-23 methacrylate/glyceryl diisostearate methacrylate copolymer, phosphorus acyl oligosaccharide calcium and steareth-200.
  • Raw materials that are listed as preservatives, sunscreens, colorants, hair dyes, and restricted components in the IECIC draft should comply with the safety and technical standards for cosmetics (2015 edition).
  • A large number of orchid extracts and algae extracts have been added to the IECIC list (draft)

Once implemented, the total number of existing cosmetic ingredients covered in the IECIC will be increased from 8,783 to 8,980.

By Jacky Li. Contact Cisema if you would like to learn more.

What you can read next

Hong Kong listing of medical device
Hong Kong listing of medical device to become a public tender condition
CMDE Analyzes the Typical Issues for Combination Product Registrations
5 Raw Materials Added to the Health Food Raw Materials Directory

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • Clinical trials of sodium hyaluronate complex solution

    Clinical trials of sodium hyaluronate complex solution – draft guidelines issued

    Clinical trials of sodium hyaluronate complex s...
  • China registration of ophthalmic optical measurement devices

    China registration of ophthalmic optical measurement devices – Technical review guidelines issued

    China registration of ophthalmic optical measur...
  • Pre-communication for Hainan medical device clinical RWD

    Pre-communication for Hainan medical device clinical RWD application – Trial measures implemented

    Pre-communication for Hainan medical device cli...
  • Registration platform for cosmetic raw materials safety information

    Registration platform for cosmetic raw materials safety information – Draft guidelines issued

    The registration platform for cosmetic raw mate...
  • Technical guidelines for reporting cosmetics formulas

    Technical guidelines for reporting cosmetics formulas – draft issued

    Technical guidelines for reporting cosmetics fo...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP